New York, NY - The FDA has approved Benicar® (olmesartan), a new angiotensin II inhibitor, for the treatment of hypertension, according to Forest Laboratories, Inc, the drug's US co-promotion partner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results